Shen Lian Biological: Joint Venture Company Obtains Invention Patent for AIDS Monoclonal Antibody

Shineway Biotech announced that its joint venture company, Yangzhou World Source Biotechnology Co., Ltd., recently received a patent from the National Intellectual Property Administration for the invention of "Competitive HIV Entry Inhibition by Monoclonal Antibodies Against CD4 for Treatment and Functional Cure of HIV Infection". This invention patent relates to methods for preventing, treating, and functionally curing HIV infection using CD4 monoclonal antibodies, their combinations, and the use of these combinations.